How to Maximize the Likelihood of Regulatory Approval for Novel Drug Device Combination Products

Time: 10:00 am
day: Day 2


  • Learning how to navigate the regulatory landscapes of the EU and US to ensure your novel drug-device combination products gain swift approval, accelerating market entry and revenue generation
  • Discovering strategies to address the primary hurdles faced by development teams in meeting regulatory standards, ensuring smooth compliance and minimizing delays in approval processes
  • Delving into the intricacies of the EU Medical Device Regulation (MDR) to streamline the conformity assessment procedure, facilitating efficient approval pathways